Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (OSUR); Remain Bullish After Meeting with Management
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Price: $3.74 --0%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 25
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 25
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Canaccord analyst, Jeffrey Frelick, said, "OraQuick HCV pent up demand? With one-third of public health clinics ordering HCV testing today, we expect the OraQuick HCV test to be adopted for the same reasons rapid HIV testing is performed in public health clinics...Training program for Merck (NYSE: MRK) reps complete. OraSure has completed training on its OraQuick HCV test with over 200 Merck sales representatives. In addition, its physician office distributor partners have been trained and launched."
"Two down, one to go. The second HIV-OTC module was submitted to FDA in late November, while the third and final module is slated for year-end submission."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $8.76 yesterday.
Canaccord analyst, Jeffrey Frelick, said, "OraQuick HCV pent up demand? With one-third of public health clinics ordering HCV testing today, we expect the OraQuick HCV test to be adopted for the same reasons rapid HIV testing is performed in public health clinics...Training program for Merck (NYSE: MRK) reps complete. OraSure has completed training on its OraQuick HCV test with over 200 Merck sales representatives. In addition, its physician office distributor partners have been trained and launched."
"Two down, one to go. The second HIV-OTC module was submitted to FDA in late November, while the third and final module is slated for year-end submission."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $8.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- UBS Downgrades Merck (MRK) to Neutral
- Ross Stores, Inc. (ROST) PT Raised to $310 at Truist Securities
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
